Nemolizumab to Treat Lichen Planopilaris, a Noncontrolled, Prospective, Pilot Study.

Clinical trial NCT07396168 · RECRUITING

Trial details

NCT number: NCT07396168
Sponsor: The Skin Center Dermatology Group
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Lichen Plano-Pilaris

Start date: 2026-02-01
Primary completion: 2027-06-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.